BN Business News
Add your company to Business Communicator →

Business · 27/07/2006Updated: 10/17/2026 · 1 min read

FDA Classifies Fecal Calprotectin Immunological Test Systems as Class II Devices

Summary

The FDA is classifying fecal calprotectin immunological test systems as Class II devices, which will be subject to special controls, including a guidance document titled 'Class II Special Controls Guidance Document: Fecal Calprotectin Immunological Test Systems,' to ensure the safety and effectiveness of these devices.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →